期刊文献+

早期子宫颈癌淋巴结转移66例临床观察

The Clinical Observation of 66 Cases of Early Cerical Cancer Lymph Node Metastasis
下载PDF
导出
摘要 目的具体总结分析早期子宫颈癌淋巴结转移的规律以及与同步放疗化疗、预后之间的关系情况。方法对我院接受治疗的66例早期子宫颈癌淋巴结转移患者的临床资料进行回顾分析,此66例患者于术后全部进行同步化疗、放疗作为观察组,我院术后进行单纯放疗的65例患者作为对照组。比较两组的生存率及不良反应。结果观察组4年生存率达到88%,对照组的复发率以及总生存率低于观察组(P<0.05)。研究组采取放化疗方式进行治疗,短期内白细胞有所下降,部分患者有较明显的呕吐等胃肠道反应,与对照组有显著性差异。结论临床治疗结果显示,淋巴结转移俨然已经成为影响患者子宫颈癌预后主要原因,在患者术后进行同步放化疗能够有效提高患者的生存质量。 Objective Analyze rule of early cerical cancer lymph node metastasis and synchronous radiation chemotherapy. Methods Choosed clinical data of 66 cases of early cerical cancer lymph node metastasis to treat with chemoradiotherapy as study group, and choosed 65 cases to treat with radiotherapy only as controlled group. Compared survival rate and adverse effect of these two groups. Results Observation group, the 4-year survival rate of 88%, the recurrence rate of the control group, lower than the observation group (P〈0.05), and overall survival. Study group to take chemotherapy treatment, decrease in white blood cells in the short term, more significant vomiting and other gastrointestinal side effects in some patients, a significant difference with the control group. Conclusion We could use chemoradiotherapy to treat patients with early cerical cancer lymph node metastasis to improve survival rate and recurrence rate.
作者 张文先
出处 《中国医药指南》 2013年第10期452-453,共2页 Guide of China Medicine
关键词 早期子宫颈癌 淋巴结转移 术后同步放化疗 生存质量 Early cerical cancer Lymph node metastasis Chemoradiotherapy Survival quality
  • 相关文献

参考文献5

二级参考文献28

  • 1张岱,刘朝晖,李克敏,范慧,廖秦平.重组人PDCD5蛋白对干扰素γ诱导人宫颈癌SiHa细胞凋亡的增敏作用的初步探讨[J].中国妇产科临床杂志,2004,5(4):286-289. 被引量:14
  • 2刘朝晖,张岱,李克敏,廖秦平.PDCD5蛋白在正常宫颈、宫颈上皮内瘤样病变和宫颈癌中的表达[J].北京大学学报(医学版),2004,36(4):407-410. 被引量:25
  • 3程晓东,吕卫国,叶枫,陈怀增,谢幸.局部晚期子宫颈癌新辅助化疗价值的评估[J].中华妇产科杂志,2006,41(2):95-98. 被引量:66
  • 4拉莱.苏祖克,彭玉华,周康,房新志,王莉.新疆不同民族子宫颈癌发病趋势分析[J].新疆医科大学学报,2006,29(7):569-571. 被引量:81
  • 5[1]Agnaldo L,Femando M,Paulo T,et al.Clinicopathological features influencing pelvic lymph node metastasis and vaginal and parametrial involvement in patients with carcinoma of the cervix.Gynecol Obstet Invest,2005,59:92
  • 6[2]Parazzini F,Vahecchi G,Bolis G,et al.Pelvic and paraortic lymphnodal status in advanced ovarian cancer and survival.Gynecol Oncol,1999,74(1):7
  • 7[3]Creasman WT.Kohler MF.Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?Gynecol Oncol,2004,92:525
  • 8[4]Naoki Takeda,Noriali S,Mahito T,et al.Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectemy.Acta Obstet Gyneeol Seam,2002,81:1144
  • 9[5]Chen RJ,Lin YH,Chen CA,et al.Influence of histologictype and age on survival mtes for invasive cervical carcinoma in Taiwan.Gynecol Oncol,1999,73:184
  • 10[7]Petem WA,Liu PY,Barrett RJ,et al.Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.J Clin Oncol,2000,18:1606

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部